Showing results (581-590 of 607) with videos related to

Sort By:
Pageof 61
Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.
Laboratory Medicine|June 30, 2022
Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained StateTina S Ipe, Blessing Ugwumba, Horace J Spencer, et al.
Neurogastroenterology and Motility|May 11, 2026
A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake BehaviorAyesha Shah, Nicholas J Talley, Simon R Knowles, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.
Health Technology Assessment (Winchester, England)|September 11, 2024
Behaviour change intervention (education and text) to prevent dental caries in secondary school pupils: BRIGHT RCT, process and economic evaluationZoe Marshman, Hannah Ainsworth, Caroline Fairhurst, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2015
Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1Nayara Cristina Fonseca, Luana Faria da Cruz, Filipe da Silva Villela, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|February 8, 2023
An expert-based system to predict population survival rate from health dataLori H Schwacke, Len Thomas, Randall S Wells, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signalingMark Zak, Emily J Hanan, Patrick Lupardus, et al.
Journal of Medicinal Chemistry|March 19, 2004
N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agentRaj N Misra, Hai-yun Xiao, Kyoung S Kim, et al.
Pageof 61